fbpx

Zynerba's Zygel Can Beat Epidiolex, But Investment Case Still Dubious – Seeking Alpha

Zynerba's Zygel Can Beat Epidiolex, But Investment Case Still Dubious – Seeking Alpha Zynerba’s Zygel Can Beat Epidiolex, But Investment Case Still Dubious  Seeking Alpha

Zynerba jumped on news of a patent for cannabidiol-based treatment of autism spectrum disorder. The product, Zygel, allows for absorption of CBD without …

বাংলা简体中文繁體中文EnglishFrançaisDeutschहिन्दीItaliano日本語한국어मराठीPortuguêsਪੰਜਾਬੀРусскийEspañolSvenskaతెలుగుไทยTürkçeУкраїнськаTiếng Việt